Kristine Øverås Aasebø's picture

Kristine Øverås Aasebø

Senior Adviser
  • E-mailKristine.Aasebo@uib.no
  • Phone+47 988 92 567
  • Visitor Address
    Armauer Hansens hus, Haukelandsveien 28
  • Postal Address
    Postboks 7804
    5020 BERGEN
Academic article
  • Show author(s) 2020. Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis. Acta Oncologica. 417-426.
  • Show author(s) 2020. Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer. Modern Pathology.
  • Show author(s) 2020. CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup . Frontiers in Oncology. 1-11.
  • Show author(s) 2019. Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients. Cancer Medicine. 3623-3635.
  • Show author(s) 2015. High BRAF mutation frequency and marked survival differences in subgroups according to KRAS/BRAF mutation status and tumor tissue availability in a prospective population-based metastatic colorectal cancer cohort. PLOS ONE.

More information in national current research information system (CRIStin)